Significance of mycophenolate monitoring in liver transplant recipients: Toward the cut-off level

Transplantation Proceedings

Volumn 44, Issue 7, 2012, Pages 2157-2161

  Sarvary, E ^a   Nemes, B ^a   Varga, M ^a   Gaal, I ^a   Monostory, K ^b   Langer, R M ^a   Gorog, D ^a   Fazakas, J ^a   Kobori, L ^a   Fehervari, I ^a   Gerlei, Zs ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; LIVER GRAFT; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS;

DRUG MONITORING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MYCOPHENOLIC ACID;

EID: 84866316898     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.124     Document Type: Conference Paper

References (21)

1. D.R. Kuypers, Y. Le Meur, M. Cantarovich, M.J. Tredger Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation Clin J Am Soc Nephrol 5 2010 341
2. H. Jeong, B. Kaplan Therapeutic Monitoring of Mycophenolate Mofetil Clin J Am Soc Nephrol 2 2007 184
3. A.C. Allison, E.M. Eugui Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection Transplantation 80 2005 S181
4. E.M. Eugui, S.J. Almquist, C.D. Muller, A.C. Allison Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion Scand J Immunol 33 1991 161
5. T.J. Franklin, J.M. Cook The inhibition of nucleic acid synthesis by mycophenolic acid Biochem J 113 1969 515
6. G.B. Klintmalm, N.L. Ascher, R.W. Busuttil, M. Deierhoi RS-6143 for treatment-resistant human liver rejection Transplant Proc 25 1 Pt 1 1993 697
7. T. van Gelder, L.B. Hilbrands, Y. Vamrenterghem, W. Weimar A randomized double-blind, multicenter plasma concentration controlled study of the safety adn efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation Transplantation 68 1999 261
8. D.W. Holt Monitoring mycophenolic acid Am Clin Biochem 39 2002 173
9. A. Jain, R. Venkataramanan, I.S. Hamad, S. Zuckerman, S. Zhang, J. Lever Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus J Clin Pharmacol 41 2001 268
10. T. van Gelder Mycophenolate blood level monitoring: recent progress Am J Transplant 9 2009 1495
11. R. van Hest, R. Mathot, A. Vulto, W. Weimar, T. van Gelder Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation Ther Drug Monit 27 2005 163
12. L.M. Shaw, M. Korecka, R. Venkataramanan Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies Am J Transplant 3 5 2003 534 542 May
13. M. Oellerich, M. Shipkova, E. Schütz Pharmacokinetic and metabolic invetigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring Their Drug Monit 22 2000 20
14. P.J.H. Smak Gregoor, C.J. Hesse, T. van Gelder Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients Transplant Proc 30 1998 1192
15. L.M. Shaw, M. Korecka, S. Aradhye Mycophenolic acid area under the curve value in African American and Caucasian renal transplant patients are comparable J Clin Pharmacol 40 2000 624
16. B.D. Kahan The evolution of therapeutic immunosuppression and the potential impact of drug concentration monitoring Ther Drug Monit 17 1995 560
17. A.K. Trull Therapeutic monitoring of tacrolimus Ann Clin Biochem 35 1998 167
18. T.M. van Gelder, Y.M. Le Meur, L.M. Shaw Therapeutic drug monitoring of mycophenolate mofetil in transplantation Ther Drug Monit 28 2006 145
19. L.M. Shaw, B. Kaplan, D. DeNofrio Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation Ther Drug Monit 22 2000 14
20. T. Pawinski, M. Durlik, I. Szlaska Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant J Clin Pharm Ther 31 2006 27
21. B.A. Kiberd, J. Lawen, A.D. Fraser Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation Am J Transplant 4 2004 1079